Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Dyslipidaemia among Nigerian oil workers with type 2 diabetes mellitus.

Edo A, Adediran OS.

West Afr J Med. 2011 May-Jun;30(3):206-9.

PMID:
22120488
2.

Serum lipid profile of Nigerian diabetics with end stage renal disease.

Agaba EI, Duguru M, Agaba PA, Angbazo D.

West Afr J Med. 2005 Oct-Dec;24(4):305-8.

PMID:
16483045
3.

Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia.

Ismail IS, Nazaimoon W, Mohamad W, Letchuman R, Singaraveloo M, Hew FL, Shuguna C, Khalid BA.

Diabet Med. 2001 Jun;18(6):501-8.

PMID:
11472471
4.

Triglyceride profile in dyslipidaemia of type 2 diabetes mellitus.

Khan SR, Ayub N, Nawab S, Shamsi TS.

J Coll Physicians Surg Pak. 2008 May;18(5):270-3. doi: 05.2008/JCPSP.270273.

PMID:
18541079
5.
6.

Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.

Bruckert E, Baccara-Dinet M, Eschwege E.

Diabet Med. 2007 Apr;24(4):388-91. Epub 2007 Feb 28.

PMID:
17335463
7.
8.

Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.

Kesavulu MM, Giri R, Kameswara Rao B, Apparao C.

Diabetes Metab. 2000 Nov;26(5):387-92.

PMID:
11119018
9.

The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.

Erdman DM, Cook CB, Greenlund KJ, Giles WH, El-Kebbi I, Ryan GJ, Gallina DL, Ziemer DC, Dunbar VG, Phillips LS.

Diabetes Care. 2002 Jan;25(1):9-15.

PMID:
11772894
10.
11.

Plasma lipid peroxidation and totalantioxidant status among dyslipidaemic and hypertensive Nigerians with high risk of coronary heart disease.

Ogunro PS, Balogun WO, Fadero FF, Idogun ES, Oninla SO, Elemile PO, Eziyi AK.

West Afr J Med. 2009 Mar;28(2):87-91.

PMID:
19761169
12.

Intensive lipid-lowering strategy in patients with diabetes mellitus.

Kanters SD, Algra A, de Bruint TW, Erkelens DW, Banga JD.

Diabet Med. 1999 Jun;16(6):500-8.

PMID:
10391399
13.

The pattern of dyslipidemia among urban African-Americans with type 2 diabetes.

Cook CB, Erdman DM, Ryan GJ, Greenlund KJ, Giles WH, Gallina DL, El-Kebbi IM, Ziemer DC, Ernst KL, Dunbar VG, Phillips LS.

Diabetes Care. 2000 Mar;23(3):319-24.

14.

Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.

Gonzélez C, Stern MP, Mitchell BD, Valdez RA, Haffner SM, Pérez BA.

Diabetes Care. 1994 May;17(5):397-404.

PMID:
8062606
15.

Dyslipidaemia among black patients with type 2 diabetes.

Vezi ZB, Naidoo DP.

Cardiovasc J S Afr. 2005 Jul-Aug;16(4):194-8.

16.

A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.

Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N.

Indian Heart J. 2003 May-Jun;55(3):234-40.

PMID:
14560932
17.

Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic control.

Tan CE, Chew LS, Chio LF, Tai ES, Lim HS, Lim SC, Jayakumar L, Eng HK, Packard CJ.

Diabetes Res Clin Pract. 2001 Feb;51(2):107-14.

PMID:
11165690
18.

Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.

Meas T, Laloi-Michelin M, Virally M, Peynet J, Giraudeaux V, Kévorkian JP, Guillausseau PJ.

Eur J Intern Med. 2009 Mar;20(2):197-200. doi: 10.1016/j.ejim.2008.06.009. Epub 2008 Aug 15.

PMID:
19327612
19.

Levels of inflammatory markers and their correlation with dyslipidemia in diabetics.

Waheed P, Naveed AK, Farooq F.

J Coll Physicians Surg Pak. 2009 Apr;19(4):207-10. doi: 04.2009/JCPSP.207210.

PMID:
19356332
20.

Lipid profile of ambulatory patients with type 2 diabetes mellitus at Kenyatta National Hospital, Nairobi.

Otieno CF, Mwendwa FW, Vaghela V, Ogola EN, Amayo EO.

East Afr Med J. 2005 Dec;82(12 Suppl):S173-9.

PMID:
16619729

Supplemental Content

Support Center